Insiders · Profile

Doyle John Brendan

Chief Financial Officer at COGNITION THERAPEUTICS. Filing since 16 Apr 2026. CIK 0001840738

Company

Date

Role

Action

Amount

Of holding

16 Apr 2026

Chief Financial Officer

Bought

10,000

$11.30K

1.6%

1 decision on file.